Log in to save to my catalogue

Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin...

Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1428933974

Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?

About this item

Full title

Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?

Publisher

United States: Public Library of Science

Journal title

PloS one, 2013-08, Vol.8 (8), p.e73062

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Inactivation of CDH1, encoding E-cadherin, promotes cancer initiation and progression. According to a newly proposed molecular mechanism, loss of E-cadherin triggers an upregulation of the anti-apoptotic oncoprotein BCL2. Conversely, reconstitution of E-cadherin counteracts overexpression of BCL2. This reciprocal regulation is thought to be critica...

Alternative Titles

Full title

Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1428933974

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1428933974

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0073062

How to access this item